Opioids in COPD: a cause of death or a marker of illness severity?
Eur Respir J
.
2016 Nov;48(5):1521-1522.
doi: 10.1183/13993003.01573-2016.
Authors
Nicholas T Vozoris
1
2
3
,
Denis E O'Donnell
4
,
Chaim M Bell
3
5
6
7
,
Sudeep S Gill
4
5
,
Paula A Rochon
3
5
6
8
Affiliations
1
Division of Respirology, Dept of Medicine, St. Michael's Hospital, Toronto, ON, Canada nick.vozoris@utoronto.ca.
2
Keenan Research Centre in the Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, ON, Canada.
3
Dept of Medicine, University of Toronto, Toronto, ON, Canada.
4
Dept of Medicine, Queen's University, Kingston, ON, Canada.
5
Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.
6
Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada.
7
Division of General Internal Medicine, Dept of Medicine, Mount Sinai Hospital, Toronto, ON, Canada.
8
Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada.
PMID:
27799397
DOI:
10.1183/13993003.01573-2016
No abstract available
Publication types
Letter
Comment
MeSH terms
Analgesics, Opioid*
Biomarkers
Cause of Death*
Death
Humans
Pulmonary Disease, Chronic Obstructive
Severity of Illness Index
Substances
Analgesics, Opioid
Biomarkers